• Labor Versameb Forschung
  • 8747_Labor_Versameb_Forschung_Jun18_foto-eberle
  • Labor Versameb Forschung

Versameb aims to provide therapeutic solutions in multiple areas of regenerative medicines

Versameb has achieved preclinical proof of concept for regenerative activity of its lead molecule by showing a significant acceleration of tissue regeneration after different types of injuries. Our primary focus is on the development of product applications in the field of acute tissue dysfunctions, with expansion potential into neuromuscular conditions and other tissue injury paradigms. Our lead molecule is in preclinical development to potentially enter clinical trials by 2020.